Eric Cohen - Mauna Kea Insider

MKEA -- France Stock  

EUR 2.87  0.045  1.54%

CFO and VP of Fin.

Mr. Eric Cohen serves as Vice President of Finance at Mauna Kea Technologies SA. Prior to joining the Company, he served as Chief Financial Officer of Biocortech and as Deputy General Manager and Chief Financial Officer of publiclyheld Hybrigenics. Prior to joining Hybrigenics, he was Finance Director of Teva Pharmaceutical in France. He was also previously Chief Financial Officer of Radio BFM
    MBA    
33 1 48 24 03 45  http://www.maunakeatech.com
Cohen holds an MBA from University of London and a Masters in Finance from Dauphine University in Paris.

Eric Cohen Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (35.99) % which means that it has lost $35.99 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (123.6) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 6.82 M in total debt with debt to equity ratio (D/E) of 83.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mauna Kea Technologies SA has Current Ratio of 3.35 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Mauna Kea Technologies SA, a medical device company, develops and sells endomicroscopy and optical biopsy for the diagnosis and treatment of cancer and other diseases. The company was founded in 2000 and is headquartered in Paris, France. Mauna Kea operates under Medical Equipment classification in France and traded on Paris Stock Exchange.Mauna Kea Technologies SA (MKEA) is traded on Paris Stock Exchange in France. It is located in 9, rue d'Enghien and employs 81 people.

Mauna Kea Technologies Leadership Team

Olivier Regnard, CEO
Bertrand Talhouet, Director
Eric Cohen, CFO, MBA
Gilles Brisson, Chairman
Alexandre Loiseau, CEO, Ph.D
Guillaume Bailliard, President, MBA
Christopher McFadden, Director, CFA
Francois Lacombe, Executive, Ph.D
Christopher Tihansky, President, MBA
JeanLuc Boulnois, Director, MBA
Bruno Villaret, President
Joseph DeVivo, Director
Christophe Bailleul, President, MBA
Agnes Rouffiac, Director
Veronique Dentan, Director
Sebastien Cadet, Director
Sacha Loiseau, CEO, Ph.D
Molly ONeill, Director
Pierre Forest, COO
John Soto, COO
Marie Meynadier, Director

Stock Performance Indicators

Did you try this?

Run Premium Stories Now
   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Premium Stories

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.